CDKN2A and carcinoid tumor: For NSCLC a downregulation of CDKN2A was reported [36] prooving that carcinoids use a similar way as NSCLC to drive G1/S-phase transition, instead cell cycle progression in LCNEC and SCLC is driven by the contrary pathway as summarized in Figure 3.